carbon monoxide has been researched along with Cold Fingers, Hereditary in 7 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
| Excerpt | Relevance | Reference |
|---|---|---|
| "1% during follow-up, and it was significantly associated to digital ulcers, interstitial lung disease, reduction of diffusion lung of carbon monoxide <75%, teleangectasias and melanodermia, while sicca syndrome and arthralgias were associated to normal/nonspecific pattern." | 3.81 | Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications. ( Campomori, F; Colaci, M; Ferri, C; Ghizzoni, C; Giuggioli, D; Manfredi, A; Sebastiani, M, 2015) |
| "A retrospective observational study was performed on 68 SSc patients treated with 5-6 infusions of iloprost per month for 6 hours per day at a dosage of 0." | 1.72 | Intravenous iloprost in systemic sclerosis and its effect in cardiopulmonary function: a retrospective observational study. ( Amato, G; Bellofiore, S; Benenati, A; Dal Bosco, Y; Foti, R; Gagliano, C; Piazza, R; Visalli, E, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Foti, R | 6 |
| Amato, G | 3 |
| Benenati, A | 3 |
| Dal Bosco, Y | 3 |
| Piazza, R | 3 |
| Gagliano, C | 3 |
| Bellofiore, S | 3 |
| Visalli, E | 3 |
| Ghizzoni, C | 1 |
| Sebastiani, M | 1 |
| Manfredi, A | 1 |
| Campomori, F | 1 |
| Colaci, M | 1 |
| Giuggioli, D | 1 |
| Ferri, C | 1 |
| Trad, S | 1 |
| Huong, du LT | 1 |
| Frances, C | 1 |
| Wechsler, B | 1 |
| Cacoub, P | 1 |
| Costedoat, N | 1 |
| Haroche, J | 1 |
| Piette, JC | 1 |
| Hanslik, T | 1 |
| Amoura, Z | 1 |
| Fahey, PJ | 2 |
| Utell, MJ | 1 |
| Condemi, JJ | 1 |
| Green, R | 1 |
| Hyde, RW | 1 |
| Lampert, E | 1 |
| Charloux, A | 1 |
| Lonsdorfer, J | 1 |
| Frans, A | 1 |
| Yamane, K | 1 |
| Miyauchi, T | 1 |
| Suzuki, N | 1 |
| Yuhara, T | 1 |
| Akama, T | 1 |
| Suzuki, H | 1 |
| Kashiwagi, H | 1 |
| Barr, WG | 1 |
7 other studies available for carbon monoxide and Cold Fingers, Hereditary
| Article | Year |
|---|---|
Intravenous iloprost in systemic sclerosis and its effect in cardiopulmonary function: a retrospective observational study.
Topics: Carbon Monoxide; Humans; Iloprost; Raynaud Disease; Retrospective Studies; Scleroderma, Systemic | 2022 |
Intravenous iloprost in systemic sclerosis and its effect in cardiopulmonary function: a retrospective observational study.
Topics: Carbon Monoxide; Humans; Iloprost; Raynaud Disease; Retrospective Studies; Scleroderma, Systemic | 2022 |
Intravenous iloprost in systemic sclerosis and its effect in cardiopulmonary function: a retrospective observational study.
Topics: Carbon Monoxide; Humans; Iloprost; Raynaud Disease; Retrospective Studies; Scleroderma, Systemic | 2022 |
Intravenous iloprost in systemic sclerosis and its effect in cardiopulmonary function: a retrospective observational study.
Topics: Carbon Monoxide; Humans; Iloprost; Raynaud Disease; Retrospective Studies; Scleroderma, Systemic | 2022 |
Intravenous iloprost in systemic sclerosis and its effect in cardiopulmonary function: a retrospective observational study.
Topics: Carbon Monoxide; Humans; Iloprost; Raynaud Disease; Retrospective Studies; Scleroderma, Systemic | 2022 |
Intravenous iloprost in systemic sclerosis and its effect in cardiopulmonary function: a retrospective observational study.
Topics: Carbon Monoxide; Humans; Iloprost; Raynaud Disease; Retrospective Studies; Scleroderma, Systemic | 2022 |
Intravenous iloprost in systemic sclerosis and its effect in cardiopulmonary function: a retrospective observational study.
Topics: Carbon Monoxide; Humans; Iloprost; Raynaud Disease; Retrospective Studies; Scleroderma, Systemic | 2022 |
Intravenous iloprost in systemic sclerosis and its effect in cardiopulmonary function: a retrospective observational study.
Topics: Carbon Monoxide; Humans; Iloprost; Raynaud Disease; Retrospective Studies; Scleroderma, Systemic | 2022 |
Intravenous iloprost in systemic sclerosis and its effect in cardiopulmonary function: a retrospective observational study.
Topics: Carbon Monoxide; Humans; Iloprost; Raynaud Disease; Retrospective Studies; Scleroderma, Systemic | 2022 |
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications.
Topics: Adult; Aged; Autoantibodies; Capillaries; Carbon Monoxide; Diffusion; Female; Fingers; Follow-Up Stu | 2015 |
Impaired carbon monoxide diffusing capacity as a marker of limited systemic sclerosis.
Topics: Adult; Aged; Biomarkers; Carbon Monoxide; Diagnosis, Differential; Diffusion; Female; Follow-Up Stud | 2011 |
Raynaud's phenomenon of the lung.
Topics: Adult; Capillaries; Carbon Monoxide; Cold Temperature; Female; Fingers; Humans; Male; Plethysmograph | 1984 |
The concept of Raynaud's phenomenon of the lung revisited.
Topics: Adult; Blood Pressure; Carbon Monoxide; Cold Temperature; Female; Humans; Lung Diseases; Lung Volume | 1996 |
Significance of plasma endothelin-1 levels in patients with systemic sclerosis.
Topics: Adult; Aged; Autoantibodies; Carbon Monoxide; Endothelins; Enzyme-Linked Immunosorbent Assay; Female | 1992 |
Reduction of pulmonary capillary blood volume following cold exposure in patients with Raynaud's phenomenon.
Topics: Adult; Aged; Blood Volume; Capillaries; Carbon Monoxide; Cold Temperature; Female; Fingers; Humans; | 1988 |